{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:51:16Z","timestamp":1761540676068},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.thromres.2006.01.001","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T12:16:10Z","timestamp":1140869770000},"page":"85-91","source":"Crossref","is-referenced-by-count":14,"title":["Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: A multicenter, randomized, double-blind study"],"prefix":"10.1016","volume":"119","author":[{"given":"Mariapaola","family":"Sgarabotto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Dei Cas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cesare","family":"Manotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Luciana Barilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Benassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Bacchi Modena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2006.01.001_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial","volume":"288","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.thromres.2006.01.001_bib2","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1210\/er.20.3.418","article-title":"Selective estrogen receptor modulator: clinical spectrum","volume":"20","author":"Cosman","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/j.thromres.2006.01.001_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1055\/s-0037-1615643","article-title":"Effects of oral and transdermal estrogen replacement therapy on markers of coagulation, fibrinolysis, inflammation and serum lipids and lipoproteins in postmenopausal women","volume":"85","author":"Vehkavaara","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.01.001_bib4","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1055\/s-0037-1616085","article-title":"Different effects of oral and transdermal hormone replacement therapies on factor IX, APC resistance, t-PA, PAI and C-reactive protein","volume":"86","author":"Lowe","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.01.001_bib5","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJM199203263261302","article-title":"Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer","volume":"326","author":"Love","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2006.01.001_bib6","first-page":"531","article-title":"Selective estrogen receptor modulators","volume":"8","author":"Kauffman","year":"1995","journal-title":"Drug News Perspect"},{"key":"10.1016\/j.thromres.2006.01.001_bib7","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1126\/science.273.5279.1222","article-title":"Identification of an estrogen response element activated by metabolites of 17\u03b2-estradiol and raloxifene","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.thromres.2006.01.001_bib8","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ahj.2003.12.019","article-title":"Cardiovascular effects of raloxifene: the arterial and venous systems","volume":"147","author":"Blumenthal","year":"2004","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2006.01.001_bib9","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.thromres.2006.01.001_bib10","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2006.01.001_bib11","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1055\/s-0037-1615717","article-title":"The effects of hormone replacement therapy (HRT) on hemostatic variables in women with previous venous thromboembolism\u2014results from a randomized, double-blind, clinical trial","volume":"85","author":"H\u00f8ibraaten","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.01.001_bib12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1055\/s-0037-1613752","article-title":"Impaired procoagulant\u2013anticoagulant balance during hormone replacement therapy? A randomised, placebo-controlled 12-week study","volume":"83","author":"Van Baal","year":"2000","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.thromres.2006.01.001_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2165\/00002512-200522050-00005","article-title":"Pharmacological management of severe postmenopausal osteoporosis","volume":"22","author":"Gaudio","year":"2005","journal-title":"Drugs Aging"},{"issue":"4","key":"10.1016\/j.thromres.2006.01.001_bib14","first-page":"591","article-title":"Effects of estrogen and selective estrogen receptor modulators on osteoporosis","volume":"15","author":"Urano","year":"2005","journal-title":"Clin Calcium"},{"issue":"9033","key":"10.1016\/j.thromres.2006.01.001_bib15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(96)24041-3","article-title":"Case-control study of venous thromboembolism risk in users of hormone replacement therapy","volume":"348","author":"Daly","year":"1996","journal-title":"Lancet"},{"issue":"9033","key":"10.1016\/j.thromres.2006.01.001_bib16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0140-6736(96)07114-0","article-title":"Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal estrogens","volume":"348","author":"Jick","year":"1996","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2006.01.001_bib17","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1161\/01.ATV.19.4.893","article-title":"Hormone replacement therapy, inflammation, and hemostasis in elderly women","author":"Cushman","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.thromres.2006.01.001_bib18","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1001\/archinte.160.21.3315","article-title":"Effects of continuous estrogen and estrogen\u2013progestin replacement regimens on cardiovascular risk markers in postmenopausal women","volume":"160","author":"Davidson","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.thromres.2006.01.001_bib19","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/01.ATV.0000074146.36646.C8","article-title":"Effect of oral and transdermal estrogen replacement therapy on hemostatic variables associated with venous thombosis: a randomized, placebo-controlled study in post-menopausal women","volume":"23","author":"Post","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.thromres.2006.01.001_bib20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"issue":"18","key":"10.1016\/j.thromres.2006.01.001_bib21","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/jama.279.18.1445","article-title":"Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women","volume":"279","author":"Walsh","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.thromres.2006.01.001_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-0037-1614472","article-title":"The clearance of thrombin\u2013antithrombin and related serpin-enzyme complexes from the circulation: role of various hepatocyte receptors","volume":"81","author":"Wells","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2006.01.001_bib23","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1161\/01.ATV.19.12.2993","article-title":"Both raloxifene and estrogen reduce major cardiovascular risk factor in healthy postmenopausal women. A 2-years, placebo-controlled study","author":"de Valk-de Roo","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.thromres.2006.01.001_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2004.09.014","article-title":"R. Short-term effects of estrogen, tamoxifen, and raloxifene on hemostasis: a randomised-controlled study and review of the literature","volume":"116","author":"Cosman","year":"2005","journal-title":"Thromb Res"},{"issue":"2","key":"10.1016\/j.thromres.2006.01.001_bib25","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S1049-3867(01)00075-5","article-title":"Effects of SERMs on important indicators of cardiovascular health: lipoproteins, hemostatic factors, and endothelial function","volume":"11","author":"Herrington","year":"2001","journal-title":"Women's Health Issues"},{"key":"10.1016\/j.thromres.2006.01.001_bib26","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1161\/01.ATV.20.5.1404","article-title":"Postmenopausal hormone replacement therapy increases coagulation activity and fibrinolysis","author":"Teede","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806000284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384806000284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T03:02:18Z","timestamp":1555470138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384806000284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0049384806000284"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2006.01.001","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}